Evidence map›Paper›PMID 34882782›Full record

ArticleCancer2022

Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study.

Colleen M McBride, Sarita Pathak, Courtney E Johnson, Anthony J Alberg, Elisa V Bandera, Jill S Barnholtz-Sloan, Melissa L Bondy, Michele L Cote, Patricia G Moorman, Lauren C Peres and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05721326 (Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition Across Diverse Patient Populations in Gynecology Practices at Penn Medicine), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05721326 nacompletednot on this mapstarted 2023, after this paper: background citation

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition Across Diverse Patient Populations in Gynecology Practices at Penn Medicine

TypeinterventionalSponsorAbramson Cancer Center at Penn MedicineRan2023 to 2025Enrolled1,283ConditionsGenetic Predisposition to Disease, Breast Cancer Female, Ovarian Cancer, Hereditary Breast and Ovarian CancerArmsSequential EHR Communications
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Homologous Recombination Deficiency and Survival in Ovarian High-Grade Serous Carcinoma by Self-Reported Race.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Psychosocial Stress Exposures and Advanced Disease at Ovarian Cancer Diagnosis.Cancer control : journal of the Moffitt Cancer Center
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Colleen M McBrideDepartment of Behavioral, Social, and Health Education Sciences, Emory University Rollins School of Public Health, Atlanta, Georgia.ORCID 0000-0001-6061-9815
Sarita PathakDepartment of Behavioral, Social, and Health Education Sciences, Emory University Rollins School of Public Health, Atlanta, Georgia.ORCID 0000-0001-5856-1036
Courtney E JohnsonDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia.ORCID 0000-0003-4980-3499
Anthony J AlbergDepartment of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia, South Carolina.
Elisa V BanderaCancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Jill S Barnholtz-SloanDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio.ORCID 0000-0001-6190-9304
Melissa L BondyDepartment of Epidemiology and Population Health, Stanford University, Stanford, California.
Michele L CoteDepartment of Oncology, Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, Michigan.
Patricia G MoormanDepartment of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina.
Lauren C PeresDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Edward S PetersEpidemiology Program, Louisiana State University Health Sciences Center School of Public Health, New Orleans, Louisiana.ORCID 0000-0003-4928-6532
Ann G SchwartzDepartment of Oncology, Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, Michigan.
Paul D TerryDepartment of Medicine, University of Tennessee Medical Center-Knoxville, Knoxville, Tennessee.ORCID 0000-0002-0353-9197
Joellen M SchildkrautDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia.

Funding

Epidemiology of Ovarian Cancer in African-American WomenR01CA142081 · NCI · UNIVERSITY OF VIRGINIA · PI SCHILDKRAUT, JOELLEN M. · 2010 to 2015
$10.6M
Ovarian Cancer Survival in African-American WomenR01CA237318 · NCI · EMORY UNIVERSITY · PI LAWSON, ANDREW B., SCHILDKRAUT, JOELLEN M. · 2020 to 2024
$5.9M
The Role of Inflammation in the Racial Disparities in Ovarian Cancer SurvivalR00CA218681 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI PERES, LAUREN COLE · 2018 to 2020
$722k
The Role of Inflammation in the Racial Disparities in Ovarian Cancer SurvivalK99CA218681 · NCI · UNIVERSITY OF VIRGINIA · PI PERES, LAUREN COLE · 2017 to 2017
$95k
NCI NIH HHS K99 CA218681NCI NIH HHS R00 CA218681NCI NIH HHS R01 CA142081NCI NIH HHS R01 CA237318
6 · The paper itself

Abstract

backgroundRacial disparities in the uptake of cancer genetic services are well documented among African American (AA) women. Understanding the multiple social and psychological factors that can influence the uptake of genetic testing among AA women is needed.

methodsData came from 270 AA women diagnosed with ovarian cancer and participating in a population-based, case-control study of ovarian cancer who were asked about genetic testing. Logistic regression analyses tested the associations of predisposing, enabling, and need factors with reported genetic testing uptake.

resultsOne-third of the sample (35%) reported having had genetic testing. In the multivariable model, AA women with higher incomes had more than double the odds of being tested than those with the lowest income (odds ratio [OR] for $25,000-$74,999, 2.04; 95% confidence interval [CI], 1.06-3.99; OR for ≥$75,000, 2.32; 95% CI, 0.92-5.94). AA women who reported employment discrimination were significantly less likely to report genetic testing than those who did not report job discrimination (OR, 0.39; 95% CI, 0.14-0.95). Marital status, Medicaid versus other insurance, prayer frequency, and perceived social support were significantly associated with genetic testing uptake in bivariate analyses but were not significant contributors in multivariable analyses.

conclusionsConsistent with other studies of AA women, a minority of African American Cancer Epidemiology Study participants had undergone genetic testing. Having a lower income and experiencing job discrimination decreased the likelihood of testing. These results provide foundational evidence supporting the need for interventions to improve the uptake of genetic testing among AA women by reducing cost barriers and providing credible assurances that genetic results will be kept private and not affect social factors such as employability.

Indexed as

Black or African AmericanOvarian NeoplasmsCarcinoma, Ovarian EpithelialCase-Control StudiesFemaleGenetic TestingHumansUnited StatesAfrican Americandisparitiesgenetic testingovarian cancerprevention

Identifiers

PMID34882782
PMCPMC9300067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.